scholarly journals Dynamic changes of mitral valve annulus geometry at preprocedural CT: relationship with functional classes of regurgitation

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Anna Palmisano ◽  
Valeria Nicoletti ◽  
Caterina Colantoni ◽  
Caterina Beatrice Monti ◽  
Luigi Pannone ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Cardiac Cycle ◽  
Cardiac Computed Tomography ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Ct Scanner ◽  
Cardiac Computed Tomography Angiography ◽  
Valve Annulus ◽  
Procedural Planning

Abstract Background We investigated mitral valve annular geometry changes during the cardiac cycle in patients with severe mitral regurgitation (MR) who underwent cardiac computed tomography angiography (CCTA) prior to percutaneous mitral valve replacement or annuloplasty. Methods Fifty-one patients with severe MR and high surgical risk (Carpentier classification: 3 type I, 16 type II, 16 type IIIa, 16 type IIIb) underwent multiphase electrocardiographically gated (0–90%) CCTA, using a second generation dual-source CT scanner, as pre-procedural planning. Twenty-one patients without MR served as controls. The mitral valve annulus was segmented every 10% step of the R-R interval, according to the D-shaped segmentation model, and differences among groups were analysed by t-test or ANOVA. Results Mitral annular area and diameters were larger in MR patients compared to controls, particularly in type II. Mitral annular area varied in MR patients throughout the cardiac cycle (mean ± standard deviation of maximum and minimum area 15.6 ± 3.9 cm2versus 13.0 ± 3.5 cm2, respectively; p = 0.001), with greater difference between annular areas versus controls (2.59 ± 1.61 cm2 and 1.98 ± 0.6 cm2, p < 0.001). The largest dimension was found in systolic phases (20–40%) in most of MR patients (n = 27, 53%), independent of Carpentier type (I: n = 1, 33%; II: n = 10, 63%; IIIa: n = 8, 50%; IIIb: n = 8, 50%), and in protodiastolic phases (n = 14, 67%) for the control group. Conclusions In severe MR, mitral annular area varied significantly throughout the cardiac cycle, with a tendency towards larger dimensions in systole.

scholarly journals Implications of Aerobic Exercises and Walking Parallel to Diabetes Medications on Diabetic Sportspersons

2021 ◽  
pp. 197-204
Author(s):  
Fehmida Ayub ◽  
Abida Naseer ◽  
Saeed Javed ◽  
Adnan Asghar ◽  
Abd Rahim Mohd Shariff ◽  
...  
Keyword(s):  
Aerobic Exercise ◽  
Blood Glucose Control ◽  
Daily Basis ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Glucose Levels ◽  
Spare Time ◽  
And Control ◽  
Experimental Group

Objective: Diabetes have a central contribution with type I or type II towards the healthy lifestyles of sportspersons. Aerobic exercise and daily walking stay them fit and control their glucose levels in their bloodstream. The aim of this study was to find out the effects of aerobic exercises and walk on the sportspersons of type I and II diabetes. Methodology: The existing research has experimental design itself wherein pre-tests and post-tests were employed to make sure the novelty of results. The data was collected from the diabetic sportspersons dividing them equally into control group (N-20) and experimental group (N-20). Both groups had type I (N-20) and type II (N-20) diabetic individuals. Aerobic exercise and walk protocol was applied for six weeks on experimental group, whereas, control group continued their routine activities. Afterwards, the data was collected through pre and post treatments and edited into SPSS (v-26). The collected data was analyzed through descriptive statistics using frequencies and percentages, whereas, T-test was applied to make the differences of pre and post treatments. Results: The findings has shown that aerobic exercises and walk decrease the higher levels of glucose in blood and enable to stable glycemic balance, weight loss maintenance, decrease insulin resistance, blood pressure decrease, and blood glucose control. Conclusion: The prominent differences were observed between control and experimental groups either type I or type II. It was concluded that the sportspersons may reduce the excessive glucose engaging in aerobic exercises and walk on daily basis rather than using medications. They should spend their happy lives and get rid of medications and insulin through spending their spare time using light exercises and maintain their glucose levels in blood as well.

Serum Prolactin Levels in Women with Gross Cystic Breast Disease

1992 ◽  
Vol 7 (4) ◽  
pp. 225-229 ◽  
Author(s):  
F. Vizoso ◽  
M.T. Allende ◽  
J.L. García-Muñiz ◽  
E. Alexandre ◽  
A. Fueyo ◽  
...  
Keyword(s):  
Breast Disease ◽  
Serum Prolactin ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Normal Range ◽  
Trh Stimulation ◽  
Gross Cystic Breast Disease ◽  
Premenopausal Patients ◽  
Normal Women

Serum prolactin (PRL) concentrations at baseline and after TRH stimulation were determined in 15 healthy women and in 51 premenopausal patients suffering from Gross Cystic Breast Disease. All women were in the luteal phase of the menstrual cycle and patients were divided into three groups according to cyst type at presentation. Basal hormone levels were within the normal range in the control group and in the three cystic breast disease groups. The maximum PRL response to TRH stimulation was significantly higher (p < 0.001) in patients with type I cysts (low Na+/K+ intracystic ratio and apocrine epithelium) than in patients with type II cysts (high Na+/K+ intracystic ratio and flattened epithelium), type III cysts (intermediate Na+/K+ intracystic ratio and mixed epithelium) and in normal women. Serum PRL concentrations corresponding to samples obtained 60 and 90 minutes after stimulation remained higher in the first group of patients. These results led us to consider the existence of an altered central regulation of PRL secretion in patients with type I cysts at presentation.

Post-mortem Study of Chronic Schizophrenic Brains

1987 ◽  
Vol 151 (6) ◽  
pp. 744-752 ◽  
Author(s):  
Bente Pakkenberg
Keyword(s):  
Grey Matter ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Stereological Method ◽  
Chronic Schizophrenic ◽  
Central Grey Matter ◽  
Volume Measurements ◽  
Schizophrenic Patients ◽  
Age And Sex

Volume measurements were carried out on 29 brains from institutionalised, chronic schizophrenic patients and 30 age and sex-matched controls using a stereological method. The volumes of the total fixated brain, the hemispheres, the cortex, and the central grey matter of the schizophrenic brains were significantly reduced while the volumes of the ventricles were significantly enlarged compared with the control group. The patients had been diagnosed by a psychiatrist on the basis of their case records as having either a Type I or Type II syndrome according to the symptoms they presented in the first years of their disease. The Type II patients were found to have significantly enlarged ventricles compared with the Type I patients.

scholarly journals Is there a relationship between Lund-Mackay scale, olfactory bulb depth and width, and Keros classification in patients with nasal polyps?

2021 ◽  
Vol 11 (44) ◽  
pp. 167-173
Author(s):  
Ziya Şencan ◽  
Nuray Bayar Muluk ◽  
Mikail Inal ◽  
Selmin Perihan Kömürcü Erkmen ◽  
Ela Cömert
Keyword(s):  
Olfactory Bulb ◽  
Healthy Subjects ◽  
Older Patients ◽  
Nasal Polyps ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Positive Correlations ◽  
And Control ◽  
The Relationship

Abstract OBJECTIVE. We investigated the relationship between Lund-Mackay scale, olfactory bulb depth and width, and Keros classification in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). MATERIAL AND METHODS. In this retrospective study, paranasal sinus computed tomography (PNSCT) images of 47 patients with CRSwNP and 47 healthy subjects (control) were evaluated. In the CRSwNP group, PNSCT scans were assessed based on Lund-Mackay scale. In both groups, olfactory fossae (OF) depth and width, and Keros classification were evaluated. RESULTS. The total Lund-Mackay score was 17.1±5.9. There were no significant differences between OF depth and width values of the nasal polyps group and control group. For both groups, Type II Keros was the most detected type; secondly, Keros type I and rarely Keros type III were detected. There was no significant correlation between Lund-Mackay score (All items and total score) and OF depth and width, and Keros type. There were negative correlations between ipsilateral OF depth and width (p<0.05), whereas there were positive correlations between contralateral OF depth and width (p>0.05). Keros type was positively correlated between ipsilateral and contralateral OF depth and Keros type (p<0.05). In older patients, left OF depth and Keros type decreased (p<0.05). CONCLUSION. As a conclusion, there was no correlation between Lund-Mackay score and olfactory fossa dimensions (depth and width). When considering age, one could notice that Keros type decreased in older patients.

scholarly journals The severity of developmental dysplasia of the hip does not correlate with the abnormality in pelvic incidence

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Rongshan Cheng ◽  
Muyin Huang ◽  
Willem Alexander Kernkamp ◽  
Huiwu Li ◽  
Zhenan Zhu ◽  
...  
Keyword(s):  
Pelvic Incidence ◽  
Sagittal Plane ◽  
Three Dimensional ◽  
Developmental Dysplasia ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Computed Tomography Images ◽  
Significant Difference ◽  
Dysplasia Of The Hip

Abstract Background The purpose of this study was to investigate the association between the severity of Developmental dysplasia of the hip (DDH) and the abnormality in pelvic incidence (PI). Methods This was a retrospective study analyzing 53 DDH patients and 53 non-DDH age-matched controls. Computed tomography images were used to construct three-dimensional pelvic model. The Crowe classification was used to classify the severity of DDH. The midpoint of the femoral head centers and sacral endplates were projected to the sagittal plane of the pelvis. The PI was defined as the angle between a line perpendicular to the sacral plate at its midpoint and a line connecting this point to the axis of the femoral heads. Independent sample t-tests were used to compare the differences between the PI of DDH group and the non-DDH controls group. Kendall’s coefficient of concordance was used to determine the correlation between the severity of DDH and PI. Results Patients with DDH had a significantly (p = 0.041) higher PI than the non-DDH controls (DDH 47.6 ± 8.2°, normal 44.2 ± 8.8°). Crowe type I patients had a significantly (p = 0.038) higher PI (48.2 ± 7.6°) than the non-DDH controls. No significant difference between the PI in Crowe type II or III patients and the PI in non-DDH controls were found (Crowe type II, 50.2 ± 9.6°, p = 0.073; Crowe type III, 43.8 ± 7.2°, p = 0.930). No correlation was found between the severity of DDH and the PI (r = 0.091, p = 0.222). Conclusions No correlation was found between the severity of DDH and the PI. The study confirmed that the PI in DDH (Crowe type I) group was higher than that of the non-DDH control group, while the PI does not correlate with the severity of DDH.

Relationship Between Calcium-phosphorous Product, Native and Bioprosthetic Mitral Valve Calcifications

2017 ◽  
Vol 68 (2) ◽  
pp. 291-293
Author(s):  
Mihail Enache ◽  
Raluca Ozana Chistol ◽  
Cristina Furnica ◽  
Grigore Tinica
Keyword(s):  
Risk Factors ◽  
Mitral Valve ◽  
Structural Characteristics ◽  
Cardiac Computed Tomography ◽  
Suspected Coronary Artery Disease ◽  
Point Of View ◽  
Diabetic Patients ◽  
Cardiac Computed Tomography Angiography ◽  
Valve Dysfunction ◽  
Bioprosthetic Mitral Valve

Calcification is a common cause of failure of natural and bioprosthetic valves (BPV). Prior research on patients with chronic kidney disease identified increased calcium-phosphorus (Ca-P) product as a risk factor for both arterial and valvular calcifications, an aspect not thoroughly investigated in general population. The aims of our study were to analyse the functional impact of native and bioprosthetic mitral valve (MV) calcification detected on cardiac computed tomography angiography (CCTA), to evaluate risk factors and to assess potential differences from a morphological and chemical point of view between BPV and native MV calcification. The authors performed a retrospective study on 270 patients who underwent CCTA for suspected coronary artery disease, 225 patients with no history of MV replacement and 45 patients with bioprosthetic MV. Mitral leaflet calcification (MLC) was registered in 21 (9.33%) and mitral annular calcification (MAC) in 27 (12%) of the 225 patients suspected for CVD. Echocardiography identified MV sclerosis in 20 cases (8.89%) and MV stenosis in 12 cases (5.33%) with MLC and/or MAC. In the BPV group, 13 patients (28.89%) presented visible BPV calcification associated to echocardiographic regurgitation in 3 (30.77%) cases and higher mean transvalvular gradients. Increased Ca-P product and diabetes mellitus proved to be risk factors for both native and BPV calcification and time since surgery only for BPV calcification. Native and BPV calcification are associated to valve dysfunction and share structural characteristics, thus indicating similar calcification mechanisms. Good glycaemic control in diabetic patients and careful administration of bisphosphonates, calcium and vitamin D supplements are mandatory especially in patients with BPV in order to prevent valve dysfunction due to calcification.

Low sulphur content in atrophied human skeletal muscle: an electron probe X-ray microanalytical study

1978 ◽  
Vol 36 (2) ◽  
pp. 634-635
Author(s):  
R. Wróblewski ◽  
W. Gremski ◽  
G. M. Roomans ◽  
R. Nordemar ◽  
L. Edström
Keyword(s):  
Skeletal Muscle ◽  
Human Skeletal Muscle ◽  
Control Group ◽  
Muscle Fibres ◽  
Type I ◽  
Tissue Preparation ◽  
Type Ii ◽  
Slow Twitch ◽  
Fibre Typing ◽  
Fast Twitch

Many diseases of the human skeletal muscle involve an atrophy of the muscle fibres. In some cases mainly one of the fibre types is affected. The fibre typing system used in this study is that of Padykula and Herman, 1955 and distinguishes between type I fibres which presumably correspond to the slow-twitch fibres and type II fibres which are the fast-twitch fibres. The type II fibres can be divided into type II A, II B and II C fibres. Recent advances in instrumentation and tissue preparation have permitted an investigation of the elemental composition of individual muscle fibres of known fibre type with the aim of comparing healthy and atrophied muscle fibres.In this study we have examined ten patients suffering from rheumatoid arthritis, two patients suffering from Parkinson's disease and two patients with upper motor lesions. As a control group we have examined muscles from eight healthy controls of the same age.

Therapeutic Mechanism of Chinese Medicine on the Healing of Early and Middle Fractures in Rabbits Under the Expression Level of Bone Morphogenetic Protein-2 (BMP-2) in Bone Tissue

2022 ◽  
Vol 12 (1) ◽  
pp. 45-51
Author(s):  
Hegui Xu ◽  
Yang Liu ◽  
Yuxiong Li ◽  
Wenbing Luo ◽  
Zhenyang Liu ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Bone Morphogenetic Protein ◽  
Expression Level ◽  
Bone Morphogenetic Protein 2 ◽  
Bone Collagen ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Morphogenetic Protein ◽  
Therapeutic Mechanism

In order to explore the therapeutic mechanism of Chinese medicine on the healing of rabbits early and middle fractures, a rabbit fracture model was established in this study. The study was divided into several groups, i.e., treatment group (TG) (fed with Chinese medicine Capsule) and control group (CG) (fed with normal saline (NS)). The materials were collected at 1, 3, and 5 weeks after the start of the experiment for analysis. The experiment content included: callus Hematoxylin-Eosin staining (HE staining); Bone Morphogenetic protein-2 (BMP-2) protein level detection; Type I and type II bone collagen (BC) detection; and serum biochemical factors detection. The experimental results showed that the formation of callus in the TG was better than in the CG; the BMP-2 protein expression level in the TG was higher than in the CG, and there were statistically significant differences (SSDs); the type I and type II BC levels in the TG were higher than the CG, there were SSDs; the levels of serum calcium (SC), phosphorus ion (PI), and alkaline phosphatase (ALP) in the TG were also higher than in the CG, and there were SSDs.

Does Type II Diabetes Predispose to Retinal Vein Occlusion?

1993 ◽  
Vol 3 (3) ◽  
pp. 109-113 ◽  
Author(s):  
P.M. Dodson ◽  
C.G. Clough ◽  
S.M. Downes ◽  
E.E. Kritzinger
Keyword(s):  
Retinal Vein Occlusion ◽  
Type I Diabetes ◽  
Microvascular Complications ◽  
Control Group ◽  
Diabetic Patients ◽  
Type I ◽  
Type Ii ◽  
Medical Conditions ◽  
Vein Occlusion ◽  
Diabetic Microvascular Complications

Retinal vein occlusion (RVO) not infrequently occurs in diabetic patients. Although the aetiology is unclear, it could relate to the other microvascular complications of diabetes. In the non-diabetic, both the central (CRVO) and branch (BRVO) forms are commonly associated with hypertension and hyperlipidaemia. We have therefore studied fifty type II diabetic patients with RVO compared to a carefully matched diabetic control group (n = 50) to elucidate underlying medical conditions and hence the aetiology of RVO in diabetic patients. The two groups were well matched. Diabetics with RVO showed a strikingly high prevalence of hypertension compared to the controls (72% versus 32%: p < 0.001) and a trend to increased hyperlipidaemia (54% versus 36%). Diabetic microvascular complications were more common in the control group (diabetic retinopathy and proteinuria). No significant differences were observed in mean HbA1 or weight, but current smoking habits and blood pressure levels were increased in the diabetics with RVO. 80% of diabetic patients with the BRVO form, were hypertensive. We conclude that the main underlying medical conditions for RVO in diabetics are hypertension and hyperlipidaemia, and these may be important in the aetiology as in the non-diabetic. RVO is more common in type II rather than type I diabetes, and does not associate with the presence of diabetic microvascular complications. Clinical assessment for hypertension and hyperlipidaemia is therefore important in diabetic patients with RVO, especially if recurrence of the condition and further visual loss is to be prevented.

scholarly journals Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys

2019 ◽  
Vol 2019 ◽  
pp. 1-9 ◽  
Author(s):  
Hiroyuki Yamada ◽  
Hiroshi Mori ◽  
Yasutomo Nakanishi ◽  
Satoshi Nishikawa ◽  
Yasuaki Hashimoto ◽  
...  
Keyword(s):  
Joint Destruction ◽  
Cathepsin K ◽  
Type Ii Collagen ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Cynomolgus Monkeys ◽  
X Ray ◽  
Cathepsin K Inhibitor

We examined whether the cathepsin K inhibitor, ONO-5334, administered alone or in combination with methotrexate (MTX), could ameliorate joint destruction evoked by collagen-induced arthritis (CIA) in female cynomolgus monkeys. CIA was induced by immunizing with bovine type II collagen. ONO-5334 (30 mg/kg/day) was orally administered once daily and MTX (10 mg/body/day) twice weekly for 9 weeks. X-ray (evaluation of joint destruction) and swelling (inflammatory) scores of proximal interphalangeal (PIP), distal interphalangeal (DIP), and metacarpophalangeal (MP) joints were evaluated. Urinary concentrations of C-terminal telopeptide of type I collagen (CTX-I) and type II collagen (CTX-II) were measured. Arthritis, accompanied by bone and cartilage destruction, was successfully induced in this collagen-induced arthritis monkey model. ONO-5334 showed no suppressive effect on joint swelling, while the joint swelling scores in the MTX and combination (ONO-5334 + MTX) groups were less than 50% compared with the control group. ONO-5334 decreased X-ray score by a mean of 64% (p<0.05 vs the control group), and MTX also decreased in X-ray score by a mean of 46% but with no statistical significance. Combination of ONO-5334 and MTX further decreased the X-ray score by 28% over MTX group (74% reduction vs the control group, p<0.01). Maximum increase in CTX-I (10-fold) and CTX-II (7-fold) compared to baseline was observed at 7 and 3 weeks after the first sensitization, respectively. After treatment with ONO-5334 alone or in combination with MTX, concentrations were maintained near baseline for both markers. In conclusion, ONO-5334 prevented joint destruction but not joint inflammation in this monkey CIA model. Concomitant use of ONO-5334 with MTX reduced architectural joint destruction compared to MTX alone; therefore, ONO-5334 may help to prevent joint destruction in combination with MTX for the treatment of rheumatoid arthritis.

Sign in / Sign up

Export Citation Format

Share Document